WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002004010) INHIBITION OF TUMOR GROWTH BY A NEMATODE ANTICOAGULANT PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/004010    International Application No.:    PCT/US2001/022231
Publication Date: 17.01.2002 International Filing Date: 12.07.2001
Chapter 2 Demand Filed:    29.01.2002    
IPC:
A61K 35/56 (2006.01), A61K 38/57 (2006.01)
Applicants: ENTREMED, INC. [US/US]; 9640 Medical Center Drive, Rockville, MD 20850 (US) (For All Designated States Except US).
GREEN, Shawn, J. [US/US]; (US) (For US Only).
HEMBROUGH, Todd, A. [US/US]; (US) (For US Only)
Inventors: GREEN, Shawn, J.; (US).
HEMBROUGH, Todd, A.; (US)
Agent: PRIOR, Kimberly, J.; Suite 2800, 1100 Peachtree Street, Atlanta, GA 30309-4530 (US).
MALONE, Janina, A.; Kilpatrick Stockton LLP, Suite 2800, 1100 Peachtree Street, Atlanta, GA 30309-4530 (US)
Priority Data:
60/217,795 12.07.2000 US
Title (EN) INHIBITION OF TUMOR GROWTH BY A NEMATODE ANTICOAGULANT PROTEIN
(FR) INHIBITION DE LA CROISSANCE TUMORALE AU MOYEN D'UNE PROTEINE ANTICOAGULANTE DE NEMATODE
Abstract: front page image
(EN)The present invention relates to compositions and uses of nematode anticoagulant proteins (NAPs). More specifically, the invention relates to the use of rNAPc2 and rNAP5 for the inhibition of endothelial cell proliferation and the inhibition of angiogenesis. The invention also relates to methods for the treatment of angiogenesis-mediated diseases, such as cancer.
(FR)L'invention concerne des compositions et des utilisations de protéines anticoagulantes de nématode (NAP). Plus spécifiquement, l'invention concerne l'utilisation de rNAPc2 et rNAP5 pour l'inhibition de la prolifération de cellules endothéliales et pour l'inhibition de l'angiogénèse. L'invention concerne également des procédés de traitement de maladies à médiation d'angiogénèse, telles que le cancer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)